2fd0: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
Line 1: Line 1:
[[Image:2fd0.gif|left|200px]]
{{Seed}}
[[Image:2fd0.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2fd0|  PDB=2fd0  |  SCENE=  }}  
{{STRUCTURE_2fd0|  PDB=2fd0  |  SCENE=  }}  


'''HIV-1 DIS kissing-loop in complex with lividomycin'''
===HIV-1 DIS kissing-loop in complex with lividomycin===




==Overview==
<!--
The kissing-loop complex that initiates dimerization of genomic RNA is crucial for Human Immunodeficiency Virus Type 1 (HIV-1) replication. We showed that owing to its strong similitude with the bacterial ribosomal A site it can be targeted by aminoglycosides. Here, we present its crystal structure in complex with neamine, ribostamycin, neomycin and lividomycin. These structures explain the specificity for 4,5-disubstituted 2-deoxystreptamine (DOS) derivatives and for subtype A and subtype F kissing-loop complexes, and provide a strong basis for rational drug design. As a consequence of the different topologies of the kissing-loop complex and the A site, these aminoglycosides establish more contacts with HIV-1 RNA than with 16S RNA. Together with biochemical experiments, they showed that while rings I, II and III confer binding specificity, rings IV and V are important for affinity. Binding of neomycin, paromomycin and lividomycin strongly stabilized the kissing-loop complex by bridging the two HIV-1 RNA molecules. Furthermore, in situ footprinting showed that the dimerization initiation site (DIS) of HIV-1 genomic RNA could be targeted by these aminoglycosides in infected cells and virions, demonstrating its accessibility.
The line below this paragraph, {{ABSTRACT_PUBMED_16679451}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16679451 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16679451}}


==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: Hiv-1]]
[[Category: Hiv-1]]
[[Category: Rna]]
[[Category: Rna]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 03:44:55 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 09:34:59 2008''

Revision as of 06:35, 28 July 2008

File:2fd0.png

Template:STRUCTURE 2fd0

HIV-1 DIS kissing-loop in complex with lividomycin

Template:ABSTRACT PUBMED 16679451

About this Structure

Full crystallographic information is available from OCA.

Reference

Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell., Ennifar E, Paillart JC, Bodlenner A, Walter P, Weibel JM, Aubertin AM, Pale P, Dumas P, Marquet R, Nucleic Acids Res. 2006 May 5;34(8):2328-39. Print 2006. PMID:16679451

Page seeded by OCA on Mon Jul 28 09:34:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=2fd0&oldid=692350"